知镜 Cognispect · 医学文献与研究工作台

Toward personalized medicine in AD/ADRD through genetic-exposome dementia risk assessments.

Tolosa-Tort P, Okorie M, Chatterjee A, Boeriu AI, Sharma RU, Andrews SJ.
NPJ dementia · 2026-08-12 · PMID 42597443

文献摘要

Genetic-Exposome Dementia Risk Assessments (GEDRA) integrate genomic and environmental risk factors into actionable, patient-centered tools for Alzheimer's disease and related dementias (AD/ADRD). By enabling midlife risk stratification before biomarker or cognitive changes, GEDRA supports personalized medicine through targeted screening, tailored interventions, treatment guidance, and proactive planning. Strategic investment in GEDRA will advance responsible risk communication and translate precision prevention strategies into equitable, clinically meaningful practice.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。